Lv41
598 积分 2022-06-14 加入
In vivo chimeric antigen receptor (CAR)-T cell therapy
55分钟前
待确认
A guide to adaptive immune memory
9天前
已完结
Presetting CAR-T cells during ex vivo biomanufacturing
9天前
已完结
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
12天前
已完结
BVX001, a Bispecific ADC Targeting CD7-Positive AML with Favorable Toxicity Profile, Exhibits Significant Efficacy in Primary Patient Samples and PDX-Models
2个月前
已完结
Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial
2个月前
已完结
Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study
2个月前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
2个月前
已完结
Circular Single-Stranded DNA: Discovery, Biological Effects, and Applications
2个月前
已完结
Efficient non-viral immune cell engineering using circular single-stranded DNA-mediated genomic integration
2个月前
已完结
皖公网安备34019202002308
